Long intergenic non-protein coding RNA 2385 (LINC02385)

Long intergenic non-protein coding RNA 2385 (LINC02385) is a member of the long non-coding RNA (lncRNA) class, specifically a long intergenic non-coding RNA, meaning it does not overlap with any known protein-coding genes and exceeds 200 nucleotides in length[1][5]. LINC02385 is cataloged in gene databases but has not been characterized as a therapeutic target; its function, disease associations, and potential regulatory roles remain undefined in current scientific literature and databases. As such, it is not presently targeted by any approved drugs and is not implicated in a known biological pathway or disease process[1][5]. Key context: - LINC02385 is not a protein, receptor, enzyme, transporter, or classical therapeutic target, but rather an lncRNA, a class increasingly recognized for regulatory functions in gene expression but often lacking well-defined, individualized roles[1][5][7]. - No specific aliases, drug interactions, or biomarker uses are documented for LINC02385 as of the latest information. - No literature in current search results directly links LINC02385 with disease, therapeutic, or adverse safety relevance; it remains mostly uncharacterized[1][5].

Other names

LINC02385long intergenic non-protein coding RNA 2385